Pharmicell Co Ltd KRX:005690:
PHARMICELL: WINS 4 BILLION WON ORDER
Pharmicell Wins 4 Billion Won Order
Earlier from Pharmicell
- Pharmicell Co: Operating and net income surged in H1 2025 despite lower revenue, led by Bio-Chemical sales
- Pharmicell Co: Q1 2025 revenue and profit soared on Bio-Chemical strength and robust R&D pipeline
- Pharmicell Co: 2024 revenue up 15% and net income up 77%, led by Bio-Chemical growth and margin gains
- Pharmicell Co: Q3 2024 revenue dropped 22.8% YoY to ₩43.4B, with net income at ₩2.18B
- Pharmicell Co: H1 2024 saw lower sales and profit, but Bio-Chemical remains the main growth engine
Later from Pharmicell
- Pharmicell Wins 5.4 Billion Won Order
- Pharmicell Co: Revenue and profit surged on Bio-Chemical growth, with robust cash flow and new plant investment
- Pharmicell Wins 9 Billion Won Order
- Pharmicell Co: Revenue and profit surged on Bio Chemical growth and AI material demand, with strong margins
- Pharmicell Co: Q1 FY2026 revenue and net income surged, driven by Bio-Chemical sales and robust margins
Follow Pharmicell into a list and get an email when it puts out news.
Follow Pharmicell